Cutaneous Squamous Cell Carcinoma.

[1]  S. Arron,et al.  Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy , 2018, Head & neck.

[2]  H. Moseley,et al.  Quantifying Direct DNA Damage in the Basal Layer of Skin Exposed to UV Radiation from Sunbeds , 2018, Photochemistry and photobiology.

[3]  A. Hauschild,et al.  PD‐1 Blockade with Cemiplimab in Advanced Cutaneous Squamous‐Cell Carcinoma , 2018, The New England journal of medicine.

[4]  S. Kraft,et al.  Association of Nodal Metastasis and Mortality With Vermilion vs Cutaneous Lip Location in Cutaneous Squamous Cell Carcinoma of the Lip , 2018, JAMA dermatology.

[5]  J. Lee,et al.  Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single‐arm phase 2 clinical trial , 2018, Cancer.

[6]  V. Gebski,et al.  Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion , 2018, Head & neck.

[7]  I. Proietti,et al.  A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma , 2018, BioMed research international.

[8]  J. Cadet,et al.  Quantitative analysis of UV photolesions suggests that cyclobutane pyrimidine dimers produced in mouse skin by UVB are more mutagenic than those produced by UVC , 2018, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[9]  H. Hata,et al.  Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma , 2018, Front. Oncol..

[10]  D. Rischin,et al.  Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Lachlan McDowell,et al.  Management of Parotid Metastatic Cutaneous Squamous Cell Carcinoma: Regional Recurrence Rates and Survival , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[12]  B. Mittal,et al.  Guidelines of care for the management of cutaneous squamous cell carcinoma. , 2018, Journal of the American Academy of Dermatology.

[13]  P. Uribe,et al.  Cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy. , 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[14]  C. Schmults,et al.  Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. , 2018, Journal of the American Academy of Dermatology.

[15]  A. Seidler,et al.  Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population‐based case–control study FB‐181 , 2018, The British journal of dermatology.

[16]  C. Schmults,et al.  Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors. , 2018, Journal of the American Academy of Dermatology.

[17]  P. Gjersvik,et al.  Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study , 2017, JAMA dermatology.

[18]  G. Paolino,et al.  Histology of Non-Melanoma Skin Cancers: An Update , 2017, Biomedicines.

[19]  M. Chren,et al.  All‐cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta‐analysis , 2017, Journal of the American Academy of Dermatology.

[20]  M. Jinnin,et al.  Chronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma , 2017, Scientific Reports.

[21]  A. Wysong,et al.  SLNB in cutaneous SCC: A review of the current state of literature and the direction for the future , 2017, Journal of surgical oncology.

[22]  A. Weaver,et al.  Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population‐Based Study in Olmsted County, Minnesota, 2000 to 2010 , 2017, Mayo Clinic proceedings.

[23]  A. Wysong,et al.  The role of imaging in the management of patients with nonmelanoma skin cancer: Diagnostic modalities and applications. , 2017, Journal of the American Academy of Dermatology.

[24]  A. Bewley,et al.  Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma , 2017, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[25]  Shannon C. Trotter,et al.  Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy , 2017, Melanoma management.

[26]  K. Malloy,et al.  Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma on the Head and Neck. , 2016, JAMA otolaryngology-- head & neck surgery.

[27]  A. Henry,et al.  Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma. , 2016, JAMA dermatology.

[28]  M. Murad,et al.  Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis. , 2016, JAMA dermatology.

[29]  Jean Y. Tang,et al.  Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors. , 2016, Journal of the American Academy of Dermatology.

[30]  E. Gordon,et al.  Perceptions of Risk of Developing Skin Cancer for Diverse Audiences: Enhancing Relevance of Sun Protection to Reduce the Risk , 2016, Journal of Cancer Education.

[31]  J. Dillner,et al.  Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case–Control Study , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[32]  R. Gniadecki,et al.  Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study. , 2016, JAMA dermatology.

[33]  S. Feldman,et al.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. , 2015, JAMA dermatology.

[34]  C. Bain,et al.  Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use , 2015, Australian and New Zealand journal of public health.

[35]  O. Colegio,et al.  Skin Cancer in the Crosshairs , 2015, Transplantation direct.

[36]  P. Uribe,et al.  High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: A literature review. , 2015, Journal of the American Academy of Dermatology.

[37]  Jean Kanitakis,et al.  Histopathologic features predictive of aggressiveness of post-transplant cutaneous squamous-cell carcinomas. , 2015, Anticancer research.

[38]  J. E. Allen,et al.  Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[39]  Curtis R. Pickering,et al.  Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma , 2014, Clinical Cancer Research.

[40]  A. Balmain,et al.  Milestones in skin carcinogenesis: the biology of multistage carcinogenesis. , 2014, The Journal of investigative dermatology.

[41]  Fan Xiang,et al.  Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. , 2014, JAMA dermatology.

[42]  L. Wheless,et al.  Skin cancer in organ transplant recipients: more than the immune system. , 2014, Journal of the American Academy of Dermatology.

[43]  A. Qureshi,et al.  Invasive cutaneous squamous cell carcinoma incidence in US health care workers , 2014, Archives of Dermatological Research.

[44]  S. Arron,et al.  NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis , 2014, The Journal of investigative dermatology.

[45]  M. Davids,et al.  Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia. , 2014, JAMA dermatology.

[46]  A. Qureshi,et al.  Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  J. Leonardi-Bee,et al.  Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies , 2013, BMJ.

[48]  Jiali Han,et al.  Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. , 2013, Journal of the American Academy of Dermatology.

[49]  A. Qureshi,et al.  Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. , 2013, JAMA dermatology.

[50]  F. Song,et al.  Risk of a Second Primary Cancer after Non-melanoma Skin Cancer in White Men and Women: A Prospective Cohort Study , 2013, PLoS medicine.

[51]  W. Hwang,et al.  Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. , 2013, JAMA dermatology.

[52]  G. Edgren,et al.  Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—A Swedish population‐based study , 2013, International journal of cancer.

[53]  T L Diepgen,et al.  Occupational skin cancer induced by ultraviolet radiation and its prevention , 2012, The British journal of dermatology.

[54]  J. Paoli,et al.  Incidence of cutaneous squamous cell carcinoma in coastal and inland areas of Western Sweden. , 2011, Cancer epidemiology.

[55]  S. Toda,et al.  Infundibular (Follicular) and Infundibulocystic Squamous Cell Carcinoma: A Clinicopathological and Immunohistochemical Study , 2011, The American Journal of dermatopathology.

[56]  Fiona O'Reilly Zwald,et al.  Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. , 2011, Journal of the American Academy of Dermatology.

[57]  Fiona O'Reilly Zwald,et al.  Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. , 2011, Journal of the American Academy of Dermatology.

[58]  D. Sheehan,et al.  Adjunctive radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion , 2011, Journal of surgical oncology.

[59]  A Seidler,et al.  Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta‐analysis , 2011, The British journal of dermatology.

[60]  Lee Wheless,et al.  Nonmelanoma Skin Cancer and the Risk of Second Primary Cancers: a Systematic Review , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[61]  J. Leonardi-Bee,et al.  Interventions for non-metastatic squamous cell carcinoma of the skin. , 2010, The Cochrane database of systematic reviews.

[62]  R. Stern,et al.  Prevalence of a history of skin cancer in 2007: results of an incidence-based model. , 2010, Archives of dermatology.

[63]  A. Troxel,et al.  Diameter of Involved Nerves Predicts Outcomes in Cutaneous Squamous Cell Carcinoma with Perineural Invasion: An Investigator‐Blinded Retrospective Cohort Study , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[64]  M. Morgan,et al.  Perineural Invasion: Identification, Significance, and a Standardized Definition , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[65]  B. Schönfisch,et al.  Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. , 2008, The Lancet. Oncology.

[66]  D. Massi,et al.  Multiple cutaneous precanceroses and carcinomas from combined iatrogenic/professional exposure to arsenic , 2008, International journal of dermatology.

[67]  S. Kossard,et al.  Keratoacanthoma and Infundibulocystic Squamous Cell Carcinoma , 2008, The American Journal of dermatopathology.

[68]  D. Brewster,et al.  Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992–2003 , 2007, The British journal of dermatology.

[69]  Gail M. Williams,et al.  Prolonged Prevention of Squamous Cell Carcinoma of the Skin by Regular Sunscreen Use , 2006, Cancer Epidemiology Biomarkers & Prevention.

[70]  Graham G Giles,et al.  Non‐melanoma skin cancer in Australia: the 2002 national survey and trends since 1985 , 2006, The Medical journal of Australia.

[71]  M. Pittelkow,et al.  Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. , 2005, Journal of the American Academy of Dermatology.

[72]  Cristián Zegers Ariztía,et al.  Manual , 2002 .

[73]  T. Wobbes,et al.  Incidence and clinical course of de-novo malignancies in renal allograft recipients. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[74]  D. Brash,et al.  Ultraviolet radiation induced signature mutations in photocarcinogenesis. , 1999, The journal of investigative dermatology. Symposium proceedings.

[75]  D. English,et al.  Case‐control study of sun exposure and squamous cell carcinoma of the skin , 1998, International journal of cancer.

[76]  M A Weinstock,et al.  Nonmelanoma skin cancer in the United States: incidence. , 1994, Journal of the American Academy of Dermatology.

[77]  R. Carroll,et al.  Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. , 1992, Journal of the American Academy of Dermatology.

[78]  J. Scotto,et al.  Biologically effective ultraviolet radiation: surface measurements in the United States, 1974 to 1985. , 1988, Science.

[79]  J. Medina,et al.  Perineural invasion in squamous cell skin carcinoma of the head and neck. , 1984, American journal of surgery.

[80]  T. Fears,et al.  Changes in skin cancer morbidity between 1971-72 and 1977-78. , 1982, Journal of the National Cancer Institute.

[81]  F. Urbach,et al.  Non‐melanoma skin cancer among caucasians in four areas of the United States , 1974, Cancer.

[82]  C. Ko,et al.  Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients , 2018, JAMA dermatology.

[83]  Steven He,et al.  Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013. , 2016, Journal of the American Academy of Dermatology.

[84]  Matthew M. Johnson,et al.  Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. , 2013, JAMA dermatology.